Boston Scientific
1,720 hedge funds and large institutions have $133B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 178 funds opening new positions, 771 increasing their positions, 556 reducing their positions, and 132 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 771 | Existing positions reduced: 556
35% more first-time investments, than exits
New positions opened: 178 | Existing positions closed: 132
15% more capital inflows, than outflows
Capital inflows: $9.42B | Capital outflows: $8.22B
14% more call options, than puts
Call options by funds: $1.13B | Put options by funds: $989M
1% more funds holding
Funds holding: 1,697 → 1,720 (+23)
0.56% more ownership
Funds ownership: 91.44% → 91.99% (+0.56%)
7% less funds holding in top 10
Funds holding in top 10: 42 → 39 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
+$711M |
| 2 |
Polen Capital Management
Boca Raton,
Florida
|
+$580M |
| 3 |
Millennium Management
New York
|
+$403M |
| 4 |
Egerton Capital (UK)
London,
United Kingdom
|
+$380M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$363M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.86B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$915M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$452M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$390M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$274M |
BSX Hedge Fund Activity: Q3 2025 in Review
1,720 of the 7,660 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $133B — down 8.4% from $145B a quarter earlier.
Buyers outnumbered sellers: 178 funds opened new BSX positions and 132 closed out — a net gain of 46 holders — while 771 added to existing stakes and 556 trimmed.
The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.
- 1,720 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,697 in Q2 2025.
- Funds reported $133B of Boston Scientific stock for Q3 2025, down 8.4% quarter-over-quarter.
- 178 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +46 holders.
- The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
- The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.
Based on aggregated 13F filings for Q3 2025.